News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Medical Device Companies May Pass New 2.3% Federal Excise Tax Along to Healthcare Providers, Including Clinical Pathology Laboratories

Lots of controversy is associated with this new tax levy that was mandated by the Affordable Care Act

Will it be medical device manufacturers or their customers—including medical laboratories—who pay the new 2.3% medical device tax that became effective on January 1, 2013? That question is being asked by healthcare policymakers and experts, as well as pathologists and clinical laboratory administrators.

This new tax is mandated by the Affordable Care Act on medical device sales to healthcare providers. It taxes gross receipts of more than $5 million for manufacturers and importers of medical devices and is unpopular within the medical device industry, including in vitro diagnostics (IVD) manufacturers. (more…)

Advances in Computational Medicine May Change How Physicians Use Clinical Pathology Laboratory Tests

Physicians, including pathologists, will be able to see a more holistic picture of the mechanisms of disease using sophisticated computer-generated models

Medical diagnosis and treatment will be greatly influenced by the fast-growing field of computational medicine. It is a development with the potential to significantly change how physicians use clinical laboratory tests and anatomic pathology services.

Computational medicine describes how researchers are using sophisticated software tools to map highly complex biophysical and disease pathways. This cutting-edge imaging technology enhances their ability to decipher the complex, often non-intuitive dynamics of human disease. (more…)

Used Laboratory Equipment Finds a Place During Tough Economic Recession

Dark Daily interviews leading market maker in used and refurbished lab analyzers

Used laboratory analyzers and systems are in demand across the United States, but the economic recession is less a factor in this market than would be expected. To find out if bargain-hunting pathologists and lab executives are snapping up refurbished analyzers and instrument systems during these tough economic times, Dark Daily caught up with one of the nation’s market makers in used and refurbished laboratory equipment.

Meet Rob Rankin, President of Michigan’s Rankin Biomedical Corporation. Rankin has sold refurbished lab equipment for over 15 years. “Laboratory equipment and instrument systems form the foundation of any clinical laboratory,” notes Rankin. “For that reason, buyers of refurbished equipment want quality and reliability along with a price that generates huge cost savings when compared to other equipment purchase options.